Home Tags SpringWorks Therapeutics

Tag: SpringWorks Therapeutics

Stamford’s SpringWorks Therapeutics debuts IPO today

The gross proceeds to SpringWorks from the offering are expected to be $162 million.

Biopharma industry exec Alan Fuhrman joins SpringWorks Therapeutics board

Fuhrman previously served on the board of Stamford’s Loxo Oncology until its sale to Eli Lilly earlier this year.

Readying IPO, SpringWorks Therapeutics names new CFO

The Stamford company says it plans to apply some of the proceeds from its $115 million IPO towards a Phase 3 study of a drug candidate for treating patients with tumors that occur in connective tissue.

SpringWorks Therapeutics moving HQ to Stamford

The transcation involved assigning the lease from an existing tenant, Structured Portfolio Group, to SpringWorks Therapeutics.

FDA fast tracks SpringWorks Therapeutics drug for treatment of tumors

"The fast track designation recognizes that desmoid tumors have a substantial impact on the lives of patients," said Saqib Islam, CEO of SpringWorks Therapeutics.